Oseni 12.5/30 Oral Tablet

RxCUI: 1368416
RxNorm name: Oseni 12.5/30 Oral Tablet
Display name: Oseni 12.5/30 Oral Tablet
Full name: Oseni 12.5/30 Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OSENI	ALOGLIPTIN AND PIOGLITAZONE	Takeda Pharmaceuticals America, Inc.	4c619ed9-fe3e-4158-9938-80c6c3493d55	2025-02-28	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1368416

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
4c619ed9-fe3e-4158-9938-80c6c3493d55	Oseni 12.5/30 Oral Tablet	SY	23	These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 2013	20250228
4c619ed9-fe3e-4158-9938-80c6c3493d55	Oseni 12.5/30 (as alogliptin benzoate 17 MG / pioglitazone hydrochloride 33.06 MG) Oral Tablet	SY	23	These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 2013	20250228
4c619ed9-fe3e-4158-9938-80c6c3493d55	Oseni 12.5 MG / 30 MG Oral Tablet	PSN	23	These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 2013	20250228
4c619ed9-fe3e-4158-9938-80c6c3493d55	alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet [Oseni]	SBD	23	These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 2013	20250228